GRML

Conviction 57HealthcareScan · Tue, Sep 8, 2026

Bearish marubozu

GRML$4.33-9.14%

ResistanceSupportVol 14Insider buy

Vol MA14 7.47M

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Greenland Mines LtdBiological Products, (No Diagnostic Substances)www.greenlandmines.com ↗

Price4.33

Change-9.14%

Gap-0.42%

Rel volume0.18×

Avg volume6.32M

Avg $ vol4.94M

SMA 203.16

SMA 501.39

SMA 200—

Price vs 50+211.21%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 7.45

RSI (14)58

MACD hist-0.01

MACD crossbear · 0d

Stoch %K / %D36 / 38

ADX (14)31

+DI / −DI47 / 24

RSI divergence—

MACD divergence—

ATR %+20.36%

ADR %13.88%

52w high9.71

52w low0.1660

From 52w high-55.46%

Above 52w low+2505.42%

New 52w highNo

SqueezeOff

Bollinger width375.19%

%B0.60

Donchian pos36.23%

Donchian high11.66

Donchian low0.1580

AVWAP (52w high)6.11

vs AVWAP high-29.18%

AVWAP (52w low)0.4564

vs AVWAP low+847.63%

OBV trendUp

Chaikin MF (20)-0.25

Today vs 20d0.18×

Avg vol (14d)7.47M

Avg vol (20d)6.32M

Avg $ vol (20d)4.94M

Market cap687.03M

RS 3m (vs SPY)+1446.06%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank85.1

1 week-10.82%

1 month+2129.38%

3 months+1295.16%

6 months—

1 year—

YTD+824.15%

P/E-65.11

P/B11.87

P/S—

P/FCF—

EPS-0.2200

Div yield—

ROE-18.22%

ROA-16.23%

Debt/Eq0.01

Current10.09

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-71.56%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value678.03M

Revenue—

Net income-3.69M

Gross profit—

Free cash flow—

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out121.24M

Employees5

ListedThu, Mar 12, 2026

Free float100.83M

Float %83.2%

Short interest8.11M

Days to cover2.6d

Short volume45.6%

Squeeze score33 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank85.1 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GRML

All disclosures →

No recent disclosed trades by Congress in GRML. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GRML · 2 buys

Insider	Side	Shares	Value	Traded	Filed
LeBlanc Jeff Chief Financial Officer · Common Stock · 2026-08-25	Buy	14K	$136K	2026-08-25	2026-08-25
LeBlanc Jeff Chief Financial Officer · Common Stock · 2026-07-16	Buy	1.4M	$245K	2026-07-16	2026-07-17

SEC filings

EDGAR filings in GRML · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

GRML

Recent news

Get daily signals & real-time alerts.